These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 36817484)
1. Analysis of immunotherapeutic response-related signatures in esophageal squamous-cell carcinoma. Zheng B; Li J; Zhang M; Zhang P; Deng W; Pu Y Front Immunol; 2023; 14():1117658. PubMed ID: 36817484 [TBL] [Abstract][Full Text] [Related]
2. A fibroblast-associated signature predicts prognosis and immunotherapy in esophageal squamous cell cancer. Ren Q; Zhang P; Zhang X; Feng Y; Li L; Lin H; Yu Y Front Immunol; 2023; 14():1199040. PubMed ID: 37313409 [TBL] [Abstract][Full Text] [Related]
3. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma. Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J Front Immunol; 2021; 12():669750. PubMed ID: 34054840 [TBL] [Abstract][Full Text] [Related]
4. PLEK2 and IFI6, representing mesenchymal and immune-suppressive microenvironment, predicts resistance to neoadjuvant immunotherapy in esophageal squamous cell carcinoma. Liu J; Chen H; Qiao G; Zhang JT; Zhang S; Zhu C; Chen Y; Tang J; Li W; Wang S; Tian H; Chen Z; Ma D; Tian J; Wu YL Cancer Immunol Immunother; 2023 Apr; 72(4):881-893. PubMed ID: 36121452 [TBL] [Abstract][Full Text] [Related]
5. Single-cell transcriptomics reveals heterogeneity in esophageal squamous epithelial cells and constructs models for predicting patient prognosis and immunotherapy. Li C; Song W; Zhang J; Luo Y Front Immunol; 2023; 14():1322147. PubMed ID: 38098487 [TBL] [Abstract][Full Text] [Related]
6. Identification and validation of an autophagy-related gene signature for predicting prognosis in patients with esophageal squamous cell carcinoma. Shi X; Li Y; Pan S; Liu X; Ke Y; Guo W; Wang Y; Ruan Q; Zhang X; Ma H Sci Rep; 2022 Feb; 12(1):1960. PubMed ID: 35121801 [TBL] [Abstract][Full Text] [Related]
7. A novel and robust pyroptosis-related prognostic signature predicts prognosis and response to immunotherapy in esophageal squamous cell carcinoma. Zhang D; Zhao F; Li J; Qin X; Li S; Niu R Aging (Albany NY); 2023 Aug; 15(15):7811-7830. PubMed ID: 37561524 [TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of prognosis-related genes in the tumor microenvironment of esophageal squamous cell carcinoma. Qu J; Zhao Q; Yang L; Ping Y; Zhang K; Lei Q; Liu F; Zhang Y Int Immunopharmacol; 2021 Jul; 96():107616. PubMed ID: 34162127 [TBL] [Abstract][Full Text] [Related]
9. Heparanase is a prognostic biomarker independent of tumor purity and hypoxia based on bioinformatics and immunohistochemistry analysis of esophageal squamous cell carcinoma. Wang Y; Song T; Li K; Liu H; Han Y; Xu T; Cao F; Li Y; Yu Y World J Surg Oncol; 2022 Jul; 20(1):236. PubMed ID: 35840985 [TBL] [Abstract][Full Text] [Related]
10. A more novel and robust gene signature predicts outcome in patients with esophageal squamous cell carcinoma. Ma C; Luo H Clin Res Hepatol Gastroenterol; 2022 Dec; 46(10):102033. PubMed ID: 36265781 [TBL] [Abstract][Full Text] [Related]
11. Ferroptosis-Related lncRNA Signature Correlates with the Prognosis, Tumor Microenvironment, and Therapeutic Sensitivity of Esophageal Squamous Cell Carcinoma. Zhu J; Zhao Y; Wu G; Zhang X; Chen Q; Yang B; Guo X; Ji S; Gu K Oxid Med Cell Longev; 2022; 2022():7465880. PubMed ID: 35903713 [TBL] [Abstract][Full Text] [Related]
12. Identification of Epithelial-Mesenchymal Transition- (EMT-) Related LncRNA for Prognostic Prediction and Risk Stratification in Esophageal Squamous Cell Carcinoma. Wang P; Chen Y; Zheng Y; Fu Y; Ding Z Dis Markers; 2021; 2021():5340240. PubMed ID: 34712369 [TBL] [Abstract][Full Text] [Related]
13. Identification of TREM2-positive tumor-associated macrophages in esophageal squamous cell carcinoma: implication for poor prognosis and immunotherapy modulation. Li H; Miao Y; Zhong L; Feng S; Xu Y; Tang L; Wu C; Zhang X; Gu L; Diao H; Wang H; Wen Z; Yang M Front Immunol; 2023; 14():1162032. PubMed ID: 37187751 [TBL] [Abstract][Full Text] [Related]
14. A prognosis model for predicting immunotherapy response of esophageal cancer based on oxidative stress-related signatures. Guo J; Tong C; Shi J; Li X; Chen X Oncol Res; 2023; 32(1):199-212. PubMed ID: 38196829 [TBL] [Abstract][Full Text] [Related]
15. Oxidative stress genes in patients with esophageal squamous cell carcinoma: construction of a novel prognostic signature and characterization of tumor microenvironment infiltration. Liu W; Yang HS; Zheng SY; Luo HH; Feng YF; Lei YY BMC Bioinformatics; 2022 Sep; 23(1):406. PubMed ID: 36180848 [TBL] [Abstract][Full Text] [Related]
16. Integrative analysis of tertiary lymphoid structures and immune microenvironment in patients with esophageal carcinoma. Yao Y; Xuan H; Wang J; Gong L; Gao W Tumori; 2023 Oct; 109(5):466-480. PubMed ID: 37249074 [TBL] [Abstract][Full Text] [Related]
17. Integrative stemness characteristics associated with prognosis and the immune microenvironment in esophageal cancer. Yi L; Huang P; Zou X; Guo L; Gu Y; Wen C; Wu G Pharmacol Res; 2020 Nov; 161():105144. PubMed ID: 32810627 [TBL] [Abstract][Full Text] [Related]
18. A novel DNA damage repair gene-related prognostic model for evaluating the prognosis and tumor microenvironment infiltration of esophageal squamous cell carcinoma. Guo D; Zhang X; Du X; Yao W; Shen W; Zhu S BMC Med Genomics; 2023 Feb; 16(1):27. PubMed ID: 36803971 [TBL] [Abstract][Full Text] [Related]
19. Development and Validation of a Prognostic Gene Signature Correlated With M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma. Yao J; Duan L; Huang X; Liu J; Fan X; Xiao Z; Yan R; Liu H; An G; Hu B; Ge Y Front Oncol; 2021; 11():769727. PubMed ID: 34926275 [TBL] [Abstract][Full Text] [Related]
20. Identification of prognostic value of anoikis-related gene score model combined with tumor microenvironment score models in esophageal squamous cell carcinoma. Zhang M; Liang Y; Song P J Gene Med; 2024 Jan; 26(1):e3624. PubMed ID: 38087999 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]